nVerses Capital, LLC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 2011399 WELLINGTON, FL

Position in COLL

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$201,778

+$147,038 QoQ

Shares Held

5,574

+227.9% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#201

of 277 holders

Holding Since

Mar 2024

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

nVerses Capital, LLC holds $1,009,100 across 5 Drug Manufacturers - Specialty & Generic names. COLL ranks #4 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	4,380	$349,217
2	HIMS	Hims & Hers Health, Inc.	7,093	$245,914
3	NBIX	Neurocrine Biosciences Inc	1,259	$212,191
4	COLL	Collegium Pharmaceutical, Inc This page	5,574	$201,778
5	ESPR	Esperion Therapeutics, Inc.	19,453	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201,778	5,574	+227.9%	Shares	Sole	2026-08-04
2024-06-30	$54,740	1,700	+1600.0%	Shares	Sole	2024-07-31
2024-03-31	$3,882	100	—	Shares	Sole	2024-04-25
No filing history on record for this holder in this stock.